52 studies found for:
Phenylketonuria
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 21 | Completed |
Study to Evaluate the Response to and Safety of an 8-Day Course of Phenoptin™ Treatment in Subjects With Phenylketonuria
|
||||
| 22 |
Completed
Has Results |
Study to Evaluate the Safety and Efficacy of Phenoptin™ in Subjects With Phenylketonuria Who Have Elevated Phenylalanine Levels
|
||||
| 23 | Recruiting |
Study of a National Cohort of Adult Patients With Phenylketonuria
|
||||
| 24 | Active, not recruiting |
Follow-up of Adult Phenylketonuria (PKU) Patients
|
||||
| 25 | Unknown † |
Nutritional and Neurotransmitter Changes in PKU Subjects on BH4
|
||||
| 26 | Completed |
Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria
|
||||
| 27 | Active, not recruiting |
Safety, Tolerability, and Efficacy Study of rAvPAL-PEG Administered Daily in Subjects With Phenylketonuria (PKU)
|
||||
| 28 | Unknown † |
Kuvan Therapy in Phenylketonuria (PKU): The Effect of Blood Phenylalanine Concentration on Kuvan Response
|
||||
| 29 | Enrolling by invitation |
Phase 2 Study of Glycomacropeptide Versus Amino Acid Diet for Management of Phenylketonuria
|
||||
| 30 | Active, not recruiting |
Effect of Kuvan on Neurocognitive Function, Blood Phenylalanine Level, Safety, and Pharmacokinetics in Children With PKU
|
||||
| 31 | Terminated |
Long-Term Tetrahydrobiopterin Treatment in PKU Patients of 0-18 Years - Study on Phenylalanine Tolerance and Safety
|
||||
| 32 | Recruiting |
Neuroimaging and Neurocognitive Assessment and Response to Sapropterin Dihydrochloride Treatment in Phenylketonuria
|
||||
| 33 | Approved for marketing |
Sapropterin Expanded Access Program
|
||||
| 34 | Enrolling by invitation |
Effects of Kuvan on Melatonin Secretion
|
||||
| 35 |
Completed
Has Results |
Study of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
|
||||
| 36 | Active, not recruiting |
A Study to Evaluate Subcutaneously Administered rAvPAL-PEG in Patients With Phenylketonuria for 24 Weeks
|
||||
| 37 | Enrolling by invitation |
Long-Term Extension of a Dose Finding Study to Evaluate the Safety, Efficacy, and Tolerability of Multiple Doses of rAvPAL-PEG in Subjects With Phenylketonuria (PKU) (PAL-003)
|
||||
| 38 | Not yet recruiting |
An Open-Label Phase 3 Study of BMN 165 for Adults With PKU Not Previously Treated w/ BMN 165
|
||||
| 39 | Recruiting |
Observational Study on the Long Term Safety of Kuvan® Treatment in Patients With Hyperphenylalaninemia (HPA) Due to Phenylketonuria (PKU) or BH4 Deficiency
|
||||
| 40 | Completed |
A Phase 3, Multicenter, Open-Label Extension Study of Phenoptin in Subjects With PKU Who Have Elevated Phenylalanine Levels
|
† Indicates status has not been verified in more than two years

